Helios Kliniken Schwerin
Wismarsche Straße 393-397
19055 Schwerin
Phone:
0385-5200
Fax:
0385-520-2007
Mail:
ed.tiehdnuseg-soileh@nirewhcs.etrofp
- Number of beds: 1.039
- Number of specialist departments: 30
- Number of inpatient cases: 42.721
- Number of partial inpatient cases: 2.930
- Number of outpatient cases: 55.453
- Hospital owners: Helios Kliniken Schwerin GmbH
- Type of provider: privat
- Kardiologie und Angiologie
- Gefäß- und Thoraxchirurgie
- Klinik für Plastische, Rekonstruktive und Ästhetische Chirurgie
- Klinik für Handchirurgie
- Klinik für Unfallchirurgie
- Klinik für Neurochirurgie und Wirbelsäulenchirurgie
- Klinik für Urologie
- Orthopädie
- Frauenheilkunde und Geburtshilfe
- Klinik für Hals-, Nasen- und Ohrenheilkunde
- Augenheilkunde
- Nephrologie
- Klinik für Neurologie
- Nuklearmedizin
- Strahlenheilkunde
- Hautklinik
- Klinik für Mund-, Kiefer- und Gesichtschirurgie, Plastische Operationen
- Intensivmedizin
- Anästhesiologie
- Institut für Radiologie, Kinder- und Neuroradiologie
- Palliativmedizin
- Schmerztherapie
- Hämatologie und Onkologie
- Institut für Pathologie
- Allg. Innere Medizin, Endokrinologie, Diabetologie
- Gastroenterologie und Infektiologie
- Klinik für Pneumologie
- Kinder- und Jugendmedizin
- Kinderchirurgie
- Klinik für Allgemein- und Viszeralchirurgie
Further information
- External quality assurance according to state law
No participation
- Quality of participation in the Disease Management Programme (DMP)
No participation
| Quantity performed | 75 |
| Exception? | No exception |
| Quantity performed | 22 |
| Exception? | No exception |
| Quantity performed | 32 |
| Exception? | No exception |
| Quantity performed | 25 |
| Exception? | No exception |
| Quantity performed | 24 |
| Exception? | No exception |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 75 |
| Quantity forecast year: | 61 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 22 |
| Quantity forecast year: | 16 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 32 |
| Quantity forecast year: | 30 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 25 |
| Quantity forecast year: | 4 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 24 |
| Quantity forecast year: | 29 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| No. | Explanation |
|---|---|
| CQ01 | Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm |
| CQ02 | Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases |
| CQ05 | Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1 |
| CQ18 | Measures for quality assurance of positron emission tomography in patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma for interim staging after chemotherapy to decide on the continuation of therapy (Amended by resolution of July 15, 2021, see CQ29). |
| CQ23 | Measures for quality assurance of allogeneic stem cell transplantation with in vitro preparation of the transplant for acute lymphatic leukaemia and acute myeloid leukaemia in adults (These QA measures will expire at the end of July 1, 2021). |
| CQ24 | Quality assurance measures for allogeneic stem cell transplantation in multiple myeloma |
| CQ27 | Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR) |
| CQ25 | Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V |
| CQ28 | Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction) |
- Clarifying chat completed: no
- Clarifying chat not completed: no
- No participation in clarifying chat: no
- Notification of non-fulfilment of nursing care not made: yes
| Number | Group |
|---|---|
| 315 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 182 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 150 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
- Accessibility
- Hygiene
- Quality management and risk management
- Complaint management
- Participation emergency care
- Drug commission
Training of employees on AMTS related topics
Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)
Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)
Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)
- Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
- Zubereitung durch pharmazeutisches Personal
- Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
- Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
- Sonstige_elektronische_Unterstuetzung
Electronic documentation of the administration of drugs
- Fallbesprechungen
- Maßnahmen zur Vermeidung von Arzneimittelverwechslung
- Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
- Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
- Andere_Massnahme
- Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
- Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
- Aushändigung des Medikationsplans
- bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
Job
Explanation
Universität Rostock & MSH Medical School Hamburg
Explanation
in SN
FL05 - Participation in multi-centre Phase I/II studies
Explanation
FL09 - Doctoral supervision
Explanation
FL06 - Participation in multi-centre phase III/IV studies
Explanation
FL02 - Lectureships / teaching posts at universities of applied sciences
Explanation
Training in other healing professions
Comment
im Rahmen des kompletten Lehrkonzeptes der Helios-Kliniken Schwerin GmbH
Comment
Ausbildung als Hebamme im Sinne des dualer Studiengangs Hebammenwissenschaften
HB05 - Medical technical radiology assistant (MTRA) (m/f)
Comment
HB19 - Nursing professionals
Comment
HB12 - Medical technical laboratory assistant (MTLA) (m/f)
Comment
HB13 - Medical technical assistant for functional diagnostics (MTAF) (m/f)
Comment
- Hospital staff
- Number of pharmacists: 10
- Additional staff: 18
- Explanations: Versorgung für SN 01-06 / Leezen 01-02 und weitere Standorte
Anja Barnowsky
Beschwerdemanagement
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-520-2370
Mail: ed.tiehdnuseg-soileh@ykswonrab.ajna
Alexander Langguth
Beschwerdemanagement
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-520-5970
Mail: ed.tiehdnuseg-soileh@htuggnal.rednaxela
Claudia Schirmer
Leiterin internes Qualitätsmanagement
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-520-5363
Mail: ed.tiehdnuseg-soileh@remrihcS.aidualC
Prof. Dr. med. Jörg Ritz
ÄD und Vorsitzender der Hygienekommission
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-5200-2005
Mail: ed.tiehdnuseg-soileh@ztir.retep-greoj
Anja Barnowsky
Beschwerdemanagement
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-520-2370
Mail: ed.tiehdnuseg-soileh@ykswonrab.ajna
19055 Schwerin
Phone:
0385-5200
Fax:
0385-520-2007
Mail:
ed.tiehdnuseg-soileh@nirewhcs.etrofp
Robert Green
Pflegedirektor des Standortes Schwerin Gesamt
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-520-3200
Mail: ed.tiehdnuseg-soileh@neerg.trebor
Daniel Dellmann
Klinik Geschätsführer
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-520-2500
Mail: ed.tiehdnuseg-soileh@nnamlled.leinad
Daniel Dellmann
Geschäftsführer
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-520-2500
Mail: ed.tiehdnuseg-soileh@nnamlled.leinad
Prof. Dr.med. Jörg-Peter Ritz
Ärztlicher Direktor Haupthaus Somatik
Wismarsche Straße 393-397
19055 Schwerin
Phone: 0385-520-2050
Mail: ed.tiehdnuseg-soileh@ztir.retep-greoj
IK: 261300185
More IK: 261300185
Location number: 772916000
Old location number: 772916000
- http://www.helios-gesundheit.de Seit September 2017 kann die neue Homepage direkt über www.helios-gesundheit.de aufgerufen werden: parallel sind die Internet- und E-Mail-Adressen wie im QB angegeben erreichbar.